New Hampshire Dupixent Safety Monitoring

Updated March 2026

New Hampshire Filing Snapshot

Statute of Limitations: 3 years
SOL Type: discovery
Bar Association: New Hampshire Bar

Current Monitoring Focus

Monitoring in New Hampshire focuses on patient reports, diagnosis timelines, and whether additional risk warnings or formal litigation activity emerge.

Who Should Register for Updates in New Hampshire

Documented Dupixent use followed by cancer diagnosis.
Diagnosis of lymphoma, skin cancer, breast cancer, lung cancer, or another malignancy.
Medical records supporting treatment timeline and diagnosis timing.
Interest in receiving updates if litigation activity expands.

Register for Updates

Get notified if Dupixent safety actions or litigation activity changes in New Hampshire.